Following on from our reshoring article in Q3’s edition of Pharma’s almanac, we wrote part II of the article focussing on how nationalism is impacting the pharmaceutical supply chain, turning an intricately globalised industry into one where many nations are seeking to bring pharmaceutical manufacturing ‘home’ through reshoring. The article… Read More »
Biopharma
The Precarious Pharmaceutical Supply Chain: To Reshore or Not to Reshore – Part I
The advent of COVID-19 has resurfaced the age old debate of reshoring to mitigate against potential quality issues in the pharma supply chain. With 80% of global API coming from China and India, there’s a massive reliance on these countries to deliver a secure, reliable and quality supply chain. Pharma’s Almanac asked… Read More »
Pharma M&A Activity Chat with Nigel Walker, MD of That’s Nice LLC, Haig Barrett’s 2020 Partner of the Year.
As part of Haig Barrett’s 20th anniversary year whilst also celebrating the establishment of the London HQ of Haig Barrett Partners Ltd, I’ve decided to launch a Partner of the Year award. Whilst I’ve partnered with many outstanding people and organisations over the years, our first Partner of the Year… Read More »
Is Europe Uniquely Positioned to Lead as the World Recovers from the COVID-19 Pandemic?
As many know, I’m Armenian. I was raised in London, lived in the States for twenty years, and moved my family back to London a couple of years ago. This global perspective, coupled with a few years of experience, has provided a unique position to consider the factors that might… Read More »
Understanding a Dynamic Industry Through Mergers and Acquisitions – Nigel Walker, That’s Nice LLC
This month, we are also shining the Haig Barrett spotlight on Nigel Walker, Founder and Managing Director, of That’s Nice LLC, a research-driven marketing agency dedicated to life sciences. Nigel is celebrating his 25th year since setting up That’s Nice. This year, That’s Nice and Haig Barrett Partners are offering industry leaders in… Read More »
CDMO Experts in Bioavailability Enhancement
This article reviews alternative approaches to improve the customer experience that can be taken by both growing and established contract manufacturing organizations (CMOs), and contract development and manufacturing organizations (CDMOs). CDMO is in the Pharmaceutical industry.
Leaders of transformation – Manufacturing Chemist
After reflecting on the type of articles that I’ve created over the years, it dawned that the most diverse and enjoyable to write was when I pulled in experts in the Pharmaceutical Industry for a panel discussion. Early last year, Manufacturing Chemist (https://www.manufacturingchemist.com/) published an article featuring the CEOs and Founders… Read More »
Healthcare Executive Talk
This was certainly one of the highlights of my week in Armenia last week. Thank you to Raffy Semerdjian for the opportunity to talk to the Healthcare Executive MBA group at Yerevan State Médical University in my ‘not-so-perfect’ Armenian! It was a blast!
Creating a formula for business alignment, growth and success
At Haig Barrett Partners, we like to highlight and celebrate our successes as it’s thanks to these that we have an industry leading customer retention rate. The following case study highlights Haig Barrett’s integrated approach, which enabled the client to implement scaleable processes across multiple products and service lines. This… Read More »
The evolution of API route decisions
Excited to share Haig Barrett’s latest published article with insights from numerous industry experts – a look at pharmaceutical API route decisions including the increased application of biocatalysts. Check it out – https://www.pharmamanufacturing.com/articles/2019/the-evolution-of-api-route-decisions/ Codexis, Inc. Merck Porton Fine Chemicals Ltd.
Engineering Success: Codexis President & CEO Shares Lessons About Corporate Change Management
Given the dynamics of today’s business climate, it might come as no surprise that change management is a topic that emerges constantly as the Haig Barrett team and I interact with executives and executive leadership teams. After years leading the Haig Barrett team to help our clients thrive during periods… Read More »
Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe
I grew up in the UK, worked in Belgium and France, and have lived in the United States for more than 22 years. I have a home in Plano, Texas, and in London. To say that much of my life has been spent going back and forth over the ocean… Read More »
Getting drug pricing right – Manufacturing Chemist
In late 2017, we wrote an article on successful drug pricing. In light of COVID 19, we’re republishing this article “Pharmaceutical companies view Covid-19 as a once-in-a-lifetime business opportunity,” said Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America.” In the US, coronavirus vaccine funding has been… Read More »
Pharma M&A Protecting the Core and Maximizing Value
Article written by Bruce Miles for CPhI North America on behalf of Haig Barrett Inc. and Nice Consulting With a number of mergers and acquisitions taking place in the CRO and CMO/CDMO space, this article highlights several areas driving the success of those new organizations, including: acquisition target criteria, fit with acquiring entity, building management consensus and… Read More »
Sustainable strategies
Source – Pharma’s Almanac
Multicultural marketing is no longer innovation, it’s competitive advantage
Customer experience within the healthcare industry is important. Currently, the healthcare industry is in the midst of a turbulent global transformation, and with the advent of technology and the ability to reach consumers across country boundaries, cultural value based strategy and messaging is more important than ever before. Multicultural influence will be driving trends… Read More »